Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease.

Autor: Alcoceba M; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.; Grupo de trabajo cooperativo de linfomas y procesos linfoproliferativos de la SCLHH, Castilla y León, Spain., Stewart JP; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK., García-Álvarez M; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Díaz LG; Servicio de Medicina Nuclear, Hospital Universitario de Salamanca (HUS/IBSAL), Salamanca, Spain., Jiménez C; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Medina A; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Chillón MC; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Gazdova J; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK., Blanco O; Servicio de Anatomía Patológica, Hospital Universitario de Salamanca (HUS/IBSAL), Salamanca, Spain., Díaz FJ; Servicio de Hematologia, Complejo Asistencial de Burgos, Burgos, Spain., Peñarrubia MJ; Servicio de Hematologia, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Fernández S; Servicio de Hematologia, Complejo Asistencial Universitario de León, León, Spain., Montes C; Servicio de Radiofísica y Protección Radiológica, Hospital Universitario de Salamanca (HUS/IBSAL), Salamanca, Spain., Cabero A; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.; Grupo de trabajo cooperativo de linfomas y procesos linfoproliferativos de la SCLHH, Castilla y León, Spain., Caballero MD; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.; Grupo de trabajo cooperativo de linfomas y procesos linfoproliferativos de la SCLHH, Castilla y León, Spain., García-Sanz R; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.; Grupo de trabajo cooperativo de linfomas y procesos linfoproliferativos de la SCLHH, Castilla y León, Spain., González M; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.; Grupo de trabajo cooperativo de linfomas y procesos linfoproliferativos de la SCLHH, Castilla y León, Spain., González D; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK., Tamayo P; Servicio de Medicina Nuclear, Hospital Universitario de Salamanca (HUS/IBSAL), Salamanca, Spain., Gutiérrez NC; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., García-Sancho AM; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.; Grupo de trabajo cooperativo de linfomas y procesos linfoproliferativos de la SCLHH, Castilla y León, Spain., Sarasquete ME; Servicio de Hematologia, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC, y Centro de Investigacion del Cancer de Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 109-121. Date of Electronic Publication: 2024 May 29.

Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.

Autor: Dogliotti I; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., Jiménez C; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain. jscris@usal.es., Varettoni M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Talaulikar D; Canberra Health Services, College of Medicine, Biology and Environment Australian National University, Canberra ACT, Australia., Bagratuni T; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Ferrante M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., Pérez J; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Drandi D; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., Puig N; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Gilestro M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., García-Álvarez M; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Owen R; The Leeds Teaching Hospitals National Health Service Trust, Leeds, UK., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda Hospital, Milan, Italy., Leblond V; Département d'Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France., Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Kersten MJ; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., D'Sa S; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK., Kaščák M; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Willenbacher W; Department of Haematology and Oncology, Internal Medicine V, Innsbruck University Hospital & Syndena GmbH, Connect to Cure, Innsbruck, Austria., Roccaro AM; Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Poulain S; Laboratory of Hematology, Biology and Pathology Center, CHU of Lille, INSERM UMR-S 1277, Team 4, Oncolille, Lille, France., Morel P; Service d'Hematologie Clinique et Therapie Cellulaire, Centre Hospitalier Universitaire d'Amiens-Picardie, Amiens, France., Kyriakou C; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK., Fend F; Institute of Pathology and Comprehensive Cancer Centre, Eberhard-Karls-University, University Hospital Tübingen, Tübingen, Germany., Vos JMI; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany., Ferrero S; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Hematology Division 1U, 'AOU Città della Salute e della Scienza di Torino', Torino, Italy., García-Sanz R; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.

Publikováno v: Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 388-395. Date of Electronic Publication: 2022 Nov 26.

The relevance of human capital as a driver for innovation

Autor: Mariz-Perez, Rosa M., Teijeiro-Alvarez, M. Mercedes, Garcìa-Alvarez, M. Teresa

Publikováno v: In Cuadernos de Economía May-August 2012 35(98):68-76

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

Autor: Cabrera-Serrano AJ; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain., Sánchez-Maldonado JM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain., Ter Horst R; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria., Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., García-Martín P; Hospital Campus de la Salud, PTS, 18016 Granada, Spain., Benavente Y; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain., Landi S; Department of Biology, University of Pisa, 56126 Pisa, Italy., Clay-Gilmour A; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, SC 29208, USA., Niazi Y; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain., Rodríguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Pérez EM; Hospital Campus de la Salud, PTS, 18016 Granada, Spain., Maffei R; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy., Blanco G; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain., Giaccherini M; Department of Biology, University of Pisa, 56126 Pisa, Italy., Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA., Marasca R; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy., López-Nevot MÁ; Immunology Department, Virgen de las Nieves University Hospital, 18014 Granada, Spain., Chen-Liang T; Hematology Department, Morales Meseguer University Hospital, 30008 Murcia, Spain., Thomsen H; MSB Medical School Berlin, D-14197 Berlin, Germany., Gámez I; Hematology Department, Morales Meseguer University Hospital, 30008 Murcia, Spain., Campa D; Department of Biology, University of Pisa, 56126 Pisa, Italy., Moreno V; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Cancer Prevention and Control Program, Unit of Biomarkers and Susceptibility, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, 08907 Barcelona, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain., de Sanjosé S; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain., Marcos-Gragera R; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), 17190 Girona, Spain.; Department of Nursing, Universitat de Girona, 17007 Girona, Spain.; Josep Carreras Leukemia Research Institute, 08916 Girona, Spain., García-Álvarez M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Dierssen-Sotos T; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.; Faculty of Medicine, University of Cantabria, 39011 Santander, Spain., Jerez A; Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, 08035 Barcelona, Spain., Butrym A; Department of Cancer Prevention and Therapy, Medical University of Wrocław, 50-556 Wrocław, Poland., Norman AD; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy., Slager SL; Division of Computational Genomics, Mayo Clinic, Rochester, MN 85054, USA.; Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA., Hemminki K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic., Li Y; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Centre for Individualised Infection Medicine (CiiM) & TWINCORE, Joint Ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA., Casabonne D; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain., Alcoceba M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain., Netea MG; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany., Försti A; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada (UGR), 18012 Granada, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 28; Vol. 24 (9). Date of Electronic Publication: 2023 Apr 28.